Singapore Medical Group Ltd
SGX:5OT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Singapore Medical Group Ltd
Total Equity
Singapore Medical Group Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Singapore Medical Group Ltd
SGX:5OT
|
Total Equity
S$167.9m
|
CAGR 3-Years
9%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
|
Cordlife Group Ltd
SGX:P8A
|
Total Equity
S$134.1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Q & M Dental Group (Singapore) Ltd
SGX:QC7
|
Total Equity
S$104.4m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
1%
|
|
|
T
|
Talkmed Group Ltd
SGX:5G3
|
Total Equity
S$84m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
|
|
A
|
Aoxin Q & M Dental Group Ltd
SGX:1D4
|
Total Equity
¥348.8m
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
HC Surgical Specialists Ltd
SGX:1B1
|
Total Equity
S$23.1m
|
CAGR 3-Years
25%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Singapore Medical Group Ltd
Glance View
Singapore Medical Group Ltd. is an investment holding company, which engages in the management of medical clinics; and provision of general medical services. The company employs 296 full-time employees The company went IPO on 2009-07-23. The Company’s Health, Diagnostic & Aesthetics and Others. The Health segment comprises obstetrical and gynecological services; oncology services, including the prevention, diagnosis and treatment of cancer, cancer screening and cancer genetic and risk assessment; pediatrics services; general medicine and health screening services; cardiology services, and endocrinology services. The Diagnostic & Aesthetics segment comprises radiology and diagnostic imaging services; refractive surgery services; dental services including general dental services, prosthodontics, orthodontics, implant dentistry, oral surgery and gum treatment and aesthetics medicine services that offer healthcare services related to physical appearances. The Others segment comprises group-level corporate services as well as business consultancy functions and telemedicine services.
See Also
What is Singapore Medical Group Ltd's Total Equity?
Total Equity
167.9m
SGD
Based on the financial report for Dec 31, 2021, Singapore Medical Group Ltd's Total Equity amounts to 167.9m SGD.
What is Singapore Medical Group Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
48%
Over the last year, the Total Equity growth was 9%. The average annual Total Equity growth rates for Singapore Medical Group Ltd have been 9% over the past three years , 48% over the past five years .
